Last update 01 Nov 2024
SPH (Benxi) North Pharmaceutical Co., Ltd.
Subsidiary Company|
2005|
Liaoning Sheng, China
Last update 01 Nov 2024
Overview
Tags
Neoplasms
Skin and Musculoskeletal Diseases
Other Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
SPH4336片在中国健康受试者中单中心、随机、开放、单次给药、两周期、两序列交叉设计的食物影响研究
[Translation] A single-center, randomized, open-label, single-dose, two-period, two-sequence crossover design food effect study of SPH4336 tablets in Chinese healthy subjects
SPH3348片在中国健康受试者中单中心、随机、开放、单次给药、两周期、两序列交叉设计的食物影响研究
[Translation] A single-center, randomized, open-label, single-dose, two-period, two-sequence crossover design study on the food effect of SPH3348 tablets in Chinese healthy subjects
评估SPH5030片在HER2阳性晚期实体瘤患者中单次及多次给药安全性、耐受性、药代动力学特征的I期研究
[Translation] A Phase I study to evaluate the safety, tolerability, and pharmacokinetic characteristics of single and multiple doses of SPH5030 tablets in patients with HER2-positive advanced solid tumors
100 Clinical Results associated with SPH (Benxi) North Pharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with SPH (Benxi) North Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with SPH (Benxi) North Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 17 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
3
1
Phase 3 Clinical
NDA/BLA
1
2
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free